Fig. 1From: Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 monthsFluorodeoxyglucose positron emission tomography (FDG-PET) performed in different times are shown: a FDG-PET performed in March 2013 (before trametinib treatment); b FDG-PET performed in May 2015 after 20 months of trametinib treatmentBack to article page